succinylacetone has been researched along with Hypertension in 2 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soong, J | 1 |
| Adams, MA | 2 |
| Nakatsu, K | 2 |
| Bourque, SL | 1 |
| Benjamin, CD | 1 |
2 other studies available for succinylacetone and Hypertension
| Article | Year |
|---|---|
Acute depletion of heme by succinylacetone alters vascular responses but does not induce hypertension.
Topics: Animals; Blood Pressure; Blood Vessels; Enzyme Inhibitors; Heme; Heme Oxygenase (Decyclizing); Hepta | 2008 |
Lack of hemodynamic effects after extended heme synthesis inhibition by succinylacetone in rats.
Topics: Aminolevulinic Acid; Animals; Blood Pressure; Guanylate Cyclase; Heme; Hemodynamics; Heptanoates; Hy | 2010 |